logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
INDP
Indaptus Therapeutics, Inc.
1.19
100 x 1.15
1 x 1.26
bid
ask
+
0.00
0.00%
99 @ 04:00 PM
1.23 +0.04 (3.53%)
Ytd-59.11%
1y-84.74%
1.18
day range
1.29
0.92
52 week range
8.69
Open1.23Prev Close1.19Low1.18High1.29Mkt Cap134.76M
Vol41.09KAvg Vol1.03MEPS-15.40P/E-0.08Forward P/E-0.64
Beta1.13Short Ratio0.54Inst. Own6.00%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-1450-d Avg2.62200-d Avg2.371yr Est8.50

INDP News

Abbott Cooper PLLC Announces Investigation on Behalf of Indaptus Therapeutics, Inc. Stockholders
globenewswire.com
Abbott Cooper PLLC Announces Investigation on Behalf of Indaptus Therapeutics, Inc. Stockholders

STAMFORD, Conn., June 17, 2026 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating potential leg

Ouster, Datavault AI, Paranovus Entertainment Technology And Other Big Stocks Moving Higher On Monday
benzinga.com
Ouster, Datavault AI, Paranovus Entertainment Technology And Other Big Stocks Moving Higher On Monda

U.S. stocks higher with Nasdaq up 2%. Ouster shares rise 15.8%, PAVS gains 92.1%. Other big gains in

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com
Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures rise, Nasdaq up 1%. Graham Corp shares down 8.7%. Other stocks declining in pre-m

Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

href=https://www.benzinga.com/quote/RMSG target=_blank>(NASDAQ: RMSG) lost 67.6% to $0.69 in

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

Why Solidion Technology Shares Are Rallying Over 50%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Solidion Technology Shares Are Rallying Over 50%; Here Are 20 Stocks Moving Premarket

Solidion Technology, Inc. (NASDAQ: STI) rose 50.55% in pre-market trading on Friday after announcing

12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

Earnings Scheduled For May 15, 2026
benzinga.com
Earnings Scheduled For May 15, 2026

Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Comparing Indaptus Therapeutics (NASDAQ:INDP) & Aldeyra Therapeutics (NASDAQ:ALDX)
defenseworld.net
Comparing Indaptus Therapeutics (NASDAQ:INDP) & Aldeyra Therapeutics (NASDAQ:ALDX)

Aldeyra Therapeutics (NASDAQ: ALDX - Get Free Report) and Indaptus Therapeutics (NASDAQ: INDP - Get

Indaptus Therapeutics (INDP) Expected to Announce Quarterly Earnings on Thursday
defenseworld.net
Indaptus Therapeutics (INDP) Expected to Announce Quarterly Earnings on Thursday

Indaptus Therapeutics (NASDAQ: INDP - Get Free Report) is expected to be issuing its results before

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
globenewswire.com
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” o

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why Multi Ways Holdings Shares Are Trading Higher By Around 60%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Multi Ways Holdings Shares Are Trading Higher By Around 60%; Here Are 20 Stocks Moving Premarket

Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit
globenewswire.com
Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” o

Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” o

Critical Review: Redhill Biopharma (NASDAQ:RDHL) and Indaptus Therapeutics (NASDAQ:INDP)
defenseworld.net
Critical Review: Redhill Biopharma (NASDAQ:RDHL) and Indaptus Therapeutics (NASDAQ:INDP)

Redhill Biopharma (NASDAQ: RDHL - Get Free Report) and Indaptus Therapeutics (NASDAQ: INDP - Get Fre

Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market ses
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday&#
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

Indaptus Therapeutics Provides Clinical Update
globenewswire.com
Indaptus Therapeutics Provides Clinical Update

Decoy20 monotherapy induces Partial Response in patient with urothelial cancer and liver metastases

Indaptus Therapeutics to Present at the H.C. Wainwright 27ᵗʰ Annual Global Investment Conference
globenewswire.com
Indaptus Therapeutics to Present at the H.C. Wainwright 27ᵗʰ Annual Global Investment Conference

NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced to

Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Company Initiates Combination Trial and Strengthens Balance Sheet to Support Continued Clinical Prog

Indaptus Therapeutics, Inc. Announces Additional Sale of $3.4 Million in Private Placement of Convertible Notes and Warrants
globenewswire.com
Indaptus Therapeutics, Inc. Announces Additional Sale of $3.4 Million in Private Placement of Conver

NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus”),

Indaptus Therapeutics Announces Reverse Stock Split
globenewswire.com
Indaptus Therapeutics Announces Reverse Stock Split

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” o
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes and Warrants
globenewswire.com
Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus”),

Indaptus Therapeutics Doses First Patient in Phase 1b/2 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab
globenewswire.com
Indaptus Therapeutics Doses First Patient in Phase 1b/2 Combination Study of Decoy20 with PD-1 Check

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-s